The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

Launched by HVIDOVRE UNIVERSITY HOSPITAL · Sep 21, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a dietary supplement called ASTARTE™ on women who frequently experience urinary tract infections (UTIs). The researchers want to see if taking this probiotic, which contains helpful bacteria, can change the balance of bacteria in the body and reduce the chances of getting another UTI over a six-month period. The goal is to help women aged 18 to 40 who have had recurrent UTIs, defined as having two or more infections in six months or more than three infections in a year.

To participate, women must be between 18 and 40 years old and have a history of recurrent UTIs. They should also be able to understand the trial and agree to follow the study guidelines. However, women who are pregnant, breastfeeding, or have certain health issues may not be eligible. If you join the study, you can expect regular check-ins to monitor your health and the effectiveness of the supplement. This research could provide important insights into new ways to prevent UTIs for women who struggle with them.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women 18-40 years of age
• • Recurrent UTI (2 times UTI within 6 months or \> 3 times UTI infection within one year).
• • The subjects should be informed about the trial protocol.
• • The subject must be able to follow the protocol, have provided voluntary consent and have signed the declaration of consent.
• Exclusion Criteria:
• • Pregnancy or planning pregnancy
• • Breastfeeding
• • Participation in another trial with probiotic the last 30 days.
• • Hypersensitivity to any ingredient in the study product
• • Patients primarily admitted for a disorder other than UTI
• • Antibiotic treatment for any other condition than UTI at time of recruitment the last 30 days